ModernVivo empowers pharmaceutical companies of all sizes, CROs, and research suppliers by transforming how in vivo studies are designed. Instead of spending months manually combing through the literature, your team can surface the most relevant information in just minutes, accelerating protocol design, improving reproducibility, and cutting costs across the R&D pipeline.

• Faster drug discovery timelines by removing barriers in literature reviews and experimental design.
• Higher quality protocols and reduced variability, ensuring robust, reproducible studies.
• Ensure alignment with ethical and regulatory best practices, including alignment with the 3Rs.
• Proven cost savings by helping teams make smarter design choices, from model selection to dosing and timing.